Cost-Effectiveness Analysis of Ziprasidone versus Haloperidol in Sequential Intramuscular/Oral Treatment of Exacerbation of Schizophrenia: Economic Subanalysis of the ZIMO Trial1 1 On behalf of the ZIMO trial collaborative group (see Acknowledgements).

By Cañas Fernando  

Clinical Drug Investigation, Vol. 27, Iss. 9, 2007-01 ,pp. : 633-645

Adis International

Access to resources Recommend Favorite

The Cost Effectiveness of Acamprosate in the Treatment of Alcoholism in Germany: Economic Evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) Study

By Schädlich P.K.   Brecht J.G.  

PharmacoEconomics, Vol. 13, Iss. 6, 1998-06 ,pp. : 719-730

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Treatments to Reduce Cholesterol Levels, Blood Pressure and Smoking for the Prevention of Coronary Heart Disease: Evaluative Study Carried Out in Spain

By Plans-Rubió P.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 623-643

Adis International

Access to resources Recommend Favorite

Ziprasidone: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Tracy Swainston Harrison   Scott Lesley J.  

CNS Drugs, Vol. 20, Iss. 12, 2006-01 ,pp. : 1027-1052

Adis International

Access to resources Recommend Favorite

Ziprasidone: A Review of its Use in Schizophrenia and Schizoaffective Disorder

By Gunasekara N.S.   Spencer C.M.   Keating G.M.  

Drugs, Vol. 62, Iss. 8, 2002-01 ,pp. : 1217-1251

Adis International

Access to resources Recommend Favorite